Abstract:Clostridium perfringens is a common opportunistic pathogen endangering livestock and poultry breeds. Here, using enhanced green fluorescent protein as screening marker, a recombinant lactobacillus tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids of C. perfringens was developed, and its immunogenicity in mice was investigated via oral administration. This probiotic vaccine could effectively induce antigen-specific secretory IgA (sIgA)-based mucosal and IgG-based humoral immune responses, and significantly high levels (p< 0.05) of cytokines IL-2, IL-4, IL-10, IL-12, IL-17, and IFN-γ were produced in immunized mice. Moreover, lymphoproliferation and percentage of CD4+ and CD8+ T cells significantly increased in mice of the probiotic vaccine group. Challenge experiments were performed in mice with C. perfringens toxinotypes A, C, and D crude toxins to evaluate protection efficiency of the probiotic vaccine, using a commercial inactivated C. perfringens vaccine made by C. perfringens toxinotypes A, C, and D as vaccine control. We observed 80% protection rate in the probiotic vaccine group, which was higher than commercial vaccine group, whereas all mice in control groups died and obvious histopathological changes were observed in liver, spleen, kidney, and intestines of mice. Significantly, we compared the immunogenicity and protection efficiency of lactobacillus constitutive expression system and lactobacillus inducible expression system, and results showed that lactobacillus constitutive expression system has obvious advantages. Our study clearly demonstrated that the probiotics vaccine could effectively induce mucosal, humoral, and cellular immunity, and provide effective protection against C. perfringens toxins, suggesting a promising strategy for the development of oral vaccine against C. perfringens.

A Combined Clostridium Perfringens/trueperella Pyogenes Inactivated Vaccine Induces Complete Immunoprotection in a Mouse Model.

Lactobacilli-derived Adjuvants Combined with Immunoinformatics-Driven Multi-Epitope Antigens Based Approach Protects Against Clostridium Perfringens in a Mouse Model

A Chimeric Protein Composed of the Binding Domains of Clostridium Perfringens Phospholipase C and Trueperella Pyogenes Pyolysin Induces Partial Immunoprotection in a Mouse Model

Potential Protective Immunogenicity of Recombinant Clostridium Perfringens Α–β2–β1 Fusion Toxin in Mice, Sows and Cows

Preparation and Evaluation of Recombinant Pyolysin, Fimbriae E and HtaA Based Protein Vaccines Against Trueperella Pyogenes

Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against Trueperella pyogenes in Mice

An EGFP-marked Recombinant Lactobacillus Oral Tetravalent Vaccine Constitutively Expressing Α, Ε, Β1, and Β2 Toxoids for Clostridium Perfringens Elicits Effective Anti-Toxins Protective Immunity.

Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin

In silico vaccine design: Targeting highly epitopic regions of Clostridium perfringens type D epsilon toxin and Clostridium novyi type B alpha toxin for optimal immunogenicity

Evaluation of the Potency of Two Pyolysin-Derived Recombinant Proteins As Vaccine Candidates of Trueperella Pyogenes in a Mouse Model: Pyolysin Oligomerization and Structural Change Affect the Efficacy of Pyolysin-Based Vaccines

Construction of live-attenuated Trueperella pyogenes by antibiotic treatment and sequential passage: methods for vaccine development

[Induced Expression of Alpha-Toxin Gene of Clostridium Perfringens in Recombinant Lactobacillus Casei and Their Immunoprotective in Mice].

Immunoinformatics design of novel multi-epitope vaccine against Trueperella Pyogenes using collagen adhesion protein, fimbriae, and pyolysin

Immunization with Pooled Antigens for Clostridium perfringens Conferred Partial Protection against Experimental Necrotic Enteritis in Broiler Chickens

DNA Vaccination Based on Pyolysin Co-Immunized with IL-1β Enhances Host Antibacterial Immunity Against Trueperella Pyogenes Infection

Three Novel Immunogenic Proteins Determined Through 2-Dimensional Electrophoresis and Mass Spectrometry with Immune Serum Confer Protection Against Challenge with Porcine Pasteurella Multocida in Mouse Models.

Immunization With A Combination Of Three Pneumococcal Proteins Confers Additive And Broad Protection Against Streptococcus Pneumoniae Infections In Mice

Chitosan-DNA Nanoparticles Enhanced the Immunogenicity of Multivalent DNA Vaccination on Mice Against Trueperella Pyogenes Infection.

Expression of the Alpha Toxin of Clostridium Perfringens in Lactobacillus Casei Genome and Evaluation of Its Immune Effects in Mice.

Protective Efficacy of a Novel Multivalent Vaccine in the Prevention of Diarrhea Induced by Enterotoxigenic Escherichia Coli in a Murine Model

A Combinatorial Vaccine Containing Inactivated Bacterin and Subunits Provides Protection Against Actinobacillus Pleuropneumoniae Infection in Mice and Pigs